Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr Samuel Danishefsky joins board at Cellceutix

This article was originally published in Scrip

Executive Summary

Dr Samuel Danishefsky is to serve on the scientific advisory board at Cellceutix (US) until July 6th, 2010. Dr Danishefsky is a leader in chemistry, specialising in the synthesis of biologically active organic compounds. He spent 14 years at Yale University, where he rose to the rank of Sterling Professor of Chemistry, the highest academic rank at the university, awarded to a tenured faculty member considered one of the best in his or her field.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003448

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel